Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLIOMIT: MRS and Clinicobiological Data in Glioblastoma
NCT07211841Not yet recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- Dec 2025
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by CHU Amiens-Picardie. Primary endpoint: Correlations between initial spectroscopic parameters, basic clinical and biological informations at 12 months. Planned start Dec 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07211841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07211841.